Effect of dexamethasone on the lymphocytic Na+/H+ antiporter activity

被引:1
|
作者
Tepel, M [1 ]
Pytlik, M [1 ]
van der Giet, M [1 ]
Schlüter, H [1 ]
Jankowski, J [1 ]
Zidek, W [1 ]
机构
[1] Ruhr Univ Bochum, Univ Klin Marienhosp, Med Klin 1, D-44625 Herne, Germany
关键词
dexamethasone; sodium/proton antiporter; lymphocytes; fluorescent dye;
D O I
10.1097/00004872-199917110-00007
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective The effects of short-term administration of dexamethasone on sodium/proton antiporter (Na+/H+ antiporter) in human lymphocytes were investigated in vitro. Methods Cytosolic pH(i) in lymphocytes was measured spectrophotometrically using the pH-sensitive fluorescent dye 2'-7'-bis-carboxyethyl-5(6)-carboxyfluorescein at 530 nm with excitation wavelengths of 440 and 530 nm. The Na+/H+ antiporter activity was determined after intracellular acidification using 100 mmol/l propionic acid. Results The addition of 1 mu mol/l dexamethasone significantly reduced cytosolic pi-ii from 7.44 +/- 0.03 to 7.25 +/- 0.05 (mean +/- SEM; P< 0.01), Incubation with dexamethasone for 40 min significantly reduced the Na+/H+ antiporter activity from (9.19 +/- 0.61) x 10(-3) PHi/S (n = 22) to (7.23 +/- 0.49) x 10(-3) pH(i)/s (n = 22; P < 0.01). The effect of dexamethasone was time and concentration dependent The apparent affinity of the Na+/H+ antiporter was not significantly different in the absence or presence of dexamethasone. The inhibition of the Na+/H+ antiporter by dexamethasone was abolished in the presence of the glucocorticoid receptor blocker, mifepristone. Conclusion Dexamethasone directly inhibits the Na+/H+ antiporter using a receptor-dependent pathway. This effect may be important for pharmacological side effects such as glucocorticoid-induced hypertension. (C) Lippincott Williams & Wilkins.
引用
收藏
页码:1553 / 1556
页数:4
相关论文
共 50 条
  • [1] Reduced Na+/H+ antiporter activity after administration of dexamethasone
    Tepel, M
    van der Giet, M
    Schlüter, H
    Jankowski, J
    Theilmeier, G
    Zidek, W
    JOURNAL OF HYPERTENSION, 2000, 18 : S205 - S205
  • [2] ABNORMALITIES IN NA+/H+ ANTIPORTER ACTIVITY IN DIABETIC NEPHROPATHY
    NG, LL
    DAVIES, JE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1992, 3 (04): : S50 - S55
  • [3] RECONSTITUTION OF A BACTERIAL NA+/H+ ANTIPORTER
    SETOYOUNG, D
    GARCIA, ML
    KRULWICH, TA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1985, 260 (21) : 1393 - 1395
  • [4] Structure of the Na+/H+ antiporter NhaA
    Hunte, Carola
    Screpanti, Emanuela
    Venturi, Miro
    Rimon, Abraham
    Padan, Etana
    Michel, Hartmut
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2006, 62 : S31 - S31
  • [5] RECONSTITUTION OF THE NA+/H+ ANTIPORTER - A NEW METHOD FOR THE DETERMINATION OF H+ EFFLUX FROM NA+/H+ ANTIPORTER-RECONSTITUTED VESICLES
    SHIBAMOTO, S
    YOSHIDA, S
    OKU, N
    HAYAKAWA, M
    HORI, T
    ITO, F
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1988, 11 (10): : 669 - 673
  • [6] CONCANAVALIN A UNMASKS NA+/H+ ANTIPORTER ACTIVITY IN PULMONARY MACROPHAGES
    BROWN, SES
    BIDANI, A
    FASEB JOURNAL, 1991, 5 (04): : A668 - A668
  • [7] CHARACTERIZATION AND PHYSIOLOGICAL ROLES OF THE NA+/H+ ANTIPORTER
    LALLEMAIN, G
    POUYSSEGUR, J
    M S-MEDECINE SCIENCES, 1987, 3 (10): : 582 - 588
  • [8] GENETIC APPROACH TO THE NA+/H+ ANTIPORTER - DISCUSSION
    ARONSON, PS
    FINE, LG
    IVES, HE
    BERL, T
    WARNOCK, DG
    SKORECKI, CL
    AUSIELLO, DA
    ADELBERG, EA
    DANIEL, TO
    DOUSA, TP
    BACALLAO, R
    IGARASHI, P
    WEINMAN, EJ
    KIDNEY INTERNATIONAL, 1987, 32 : S150 - S155
  • [9] Conformational changes in NhaA Na+/H+ antiporter
    Kozachkov, Lena
    Padan, Etana
    MOLECULAR MEMBRANE BIOLOGY, 2013, 30 (01) : 90 - 100
  • [10] Structure and function of NhaA Na+/H+ antiporter
    Padan, E
    Hunte, C
    Screpanti, E
    Michel, H
    FASEB JOURNAL, 2006, 20 (05): : A1337 - A1338